$RKLB

RKLB vs. ASTS: One Space Stock Is a Buying Opportunity, the Other Is One to Avoid, Says Investor

Rocket Lab (RKLB) and AST SpaceMobile (ASTS) are space sector stocks that have declined significantly. Rocket Lab builds satellites and has a $2.36B backlog, while AST SpaceMobile faces delays in satellite launches. Analyst The Alpha Analyst upgraded RKLB to Buy and keeps ASTS at Sell, citing RKLB's stronger revenue control and ASTS's dependency on others. RKLB trades at 16.4x EV/Sales, ASTS at 8x. Both face upcoming Q3 results and other risks.

Original reporting
Published Oct 23, 2026, 12:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RKLB
Bullish
high confidence
Mentioned
$RKLB · $ASTS
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

Analyst upgrade for RKLB and sell rating for ASTS create immediate trading signals for both tickers.

02

Market read

Provides fresh analyst viewpoints that can shift short‑term price action for the two stocks.

03

What to watch

AST's potential partnership with alternative launch providers could mitigate launch risk.

Relevance 7/10Novelty 6/10Timing: today

Background

The article compares two space‑sector stocks, providing analyst ratings, price targets, and operational updates.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

Analyst upgraded Rocket Lab to Buy with a $98.25 price target, citing Iridium deal and backlog growth.

Expected impact

likely upward pressure as investors price in higher target and deal upside

Evidence & confidence

Upgrade is fresh, includes concrete price target and deal timeline, giving a clear catalyst.

$ASTSBearishHigh confidence
Context

Analyst kept a Sell rating on AST SpaceMobile, warning of launch delays and revenue shortfall.

Expected impact

potential downside as investors react to weak guidance and launch risk

Evidence & confidence

Sell rating with specific concerns provides a clear downside catalyst.

Market effects

Highlights divergence within the space sector, favoring companies with diversified revenue streams.

U.S. space equities may see split performance based on deal exposure.

Limited to investors tracking space industry dynamics.

Counterpoint

Rocket Lab's Iridium integration risk could delay profitability, tempering the upgrade.

Key entities

  • Rocket Lab

    U.S. space launch and satellite manufacturer (NASDAQ:RKLB).

  • AST SpaceMobile

    U.S. satellite‑mobile network developer (NASDAQ:ASTS).

Related articles

$GOOGMed

Cathie Wood Trimmed Ark's Alphabet Stake Even as Google Search Revenue Grew, While Ark Piled Into Rocket Lab Even After Its Neutron Launch Delay. Is Ark Betting Against the Wrong AI Winner?

Ark Invest reduced its stake in Alphabet (GOOG, GOOGL) while increasing investments in Rocket Lab (RKLB) despite a Neutron rocket launch delay. Alphabet reported strong Q2 search and cloud revenue growth, while Rocket Lab has a backlog of $2.36B and a multiyear launch deal with Synspective. Ark's strategy focuses on potential U.S. launch capacity shortages and Rocket Lab's growth opportunities.

$ASTSMed

AST SpaceMobile Hit a 52-Week Low Days After SpaceX Spent $8 Billion on Spectrum. That's Not a Coincidence.

AST SpaceMobile (ASTS) hit a 52-week low of $39.02 on Oct. 20, 12 days after SpaceX (SPCX) acquired Grain Management's 800 MHz spectrum for $8 billion. ASTS develops LEO satellites for direct-to-cell connections, partnering with AT&T (T) and Verizon (VZ). SpaceX's move could enable Starlink to become a wireless carrier, potentially impacting ASTS's business. Analysts expect ASTS's revenue to grow from $168M in 2026 to $1.73B in 2028.

$RKLBMed

Rocket Lab stock rises 4.4% as SpaceX posts strong Q3 results

Rocket Lab shares rose 4.4% to $53.16, following SpaceX's strong Q3 results. SpaceX reported $14.58B revenue, beating estimates. Rocket Lab built the Maxwell spacecraft for Viasat. Analysts expect Rocket Lab's Q3 loss to widen but revenue to rise. The stock is in a downtrend, trading below key moving averages.

$TSLAMed

Nasdaq futures lead gains as SpaceX, Super Micro results lift AI trade

Nasdaq futures rose on Wednesday, led by gains in SpaceX (up 7.2%) and Super Micro (up 10.9%) after their earnings reports. SpaceX posted its first profit as a public company, while Super Micro exceeded revenue and profit margin estimates. Tesla (up 1.4%) also gained after Elon Musk suggested a potential merger with SpaceX. Netflix fell 6.6% after issuing a weaker-than-expected forecast. Other AI-related stocks and chipmakers also saw gains.

$RKLBHighAI 9/10

Why Is Rocket Lab Stock Rising in Pre-Market Trading?

Rocket Lab (RKLB) shares rose 3.9% in pre-market trading on Wednesday, ahead of its Q3 2026 earnings report on November 9. The company also updated investors on its NASA spacecraft mission and its proposed $8B acquisition of Iridium (IRDM), which received 99.6% shareholder approval. Rocket Lab's stock had previously fallen over 20% after delaying its Neutron rocket launch to 2027.